Advertisement
The announcement means that the VAP Test, with its unique ability toidentify far more areas of risk than the standard lipid panel, will now beavailable in Biophysical's biomarker-based health assessment.
Advertisement
"The advanced cholesterol testing made possible by the VAP Test is aperfect and natural fit for Biophysical," said Atherotech Chief MedicalOfficer James Ehrlich, M.D. "It is certainly rewarding to be included in theoffering of a company that brings so much expertise to the field of biomarkersand early detection."
The BiophysicalCheck is based on the technology used in the company'sflagship test, the Biophysical250. This test has been called "The UltimateBlood Test" by Scientific American and has been featured on highly-rated U.S.syndicated talk shows. The company anticipates adding the VAP Test to itsother assessments later this year.
"The addition of the VAP Test strengthens even further our ability todetect cardiovascular disease at an earlier, more preventable stage," saidGeorge Rodgers, M.D., chief medical officer and president of BiophysicalCorporation. "We're pleased to incorporate the VAP Test's expanded cholesteroltesting into our biomarkers for the pre-symptomatic detection of disease."
The VAP Test directly measures LDL and has been shown to identify a fargreater number of patients with lipid abnormalities than the standard lipidpanel (cholesterol and triglyceride test). The test also reports 15 separatecomponents versus four in the standard cholesterol test.
Consumers, corporations, physicians and wellness centers interested inlearning more about the VAP Test can visit http://www.thevaptest.com and/orthe Biophysical Corporation and its biomarker-based health assessments athttp://www.biophysicalcorp.com or call 800.532.7092.
About Biophysical Corporation
Biophysical Corporation is a private, Austin, Texas-based companydedicated to advancing clinical knowledge and quality of life for its clients.Formed in 2004, the company offers Biophysical250, the most comprehensive andadvanced assessment of personal health ever developed. Through the innovativeanalysis of blood-based biomarkers, Biophysical250 may indicate the presenceor risk of cancer, cardiovascular disease and other health risks often beforesymptoms appear. The company's management and advisory board includesinternationally renowned physicians and scientists who are leaders in thefield of biomarker research. More information about the company andBiophysical250 is available at http://www.biophysicalcorp.com or by calling800.532.7092.
About Atherotech, Inc.
Atherotech is a cardio-diagnostic company focusing on direct measurementof the comprehensive lipid panel using the company's patented VAP technology,which reports the cholesterol content of all lipids, components andsubclasses. The VAP Test is the first cholesterol profile to comply withupdated National Cholesterol Education Program ATP III recommendations for LDLmeasurement and the only commercially available advanced lipid profile thatroutinely reports all three lipoprotein parameters considered necessary by theAmerican Diabetes Association and American College of Cardiology expertconsensus guidelines. The VAP Cholesterol Test is available through nationaland regional diagnostic laboratories and is reimbursed by many of the largestprivate insurers as well as Medicare. For more information, visithttp://www.thevaptest.com.
Biophysical is a registered trademark of Biophysical Corporation.Biophysical250 and BiophysicalCheck are trademarks of Biophysical Corporation.
SOURCE Atherotech, Inc.
